Concord Biotech Shareholding Pattern
- Market cap
- ₹14,215 crore
- P/E
- 52.0
- P/B
- 7.05
- ROE
- 13.6%
- Dividend yield
- 0.56%
As of 30-JUN-2026, promoters held 44.08% of Concord Biotech (0.00 pp from 31-MAR-2026), foreign institutional investors 7.52%, domestic institutions 9.36% and the public 39.03%.
Source: Shareholding patterns filed with the stock exchanges (company filings). Data as of 7 October 2026. How this data is compiled.
Concord Biotech shareholding pattern — frequently asked questions
What is the promoter holding in Concord Biotech?
Promoters held 44.08% of Concord Biotech as of 30-JUN-2026, unchanged from 44.08% in 31-MAR-2026.
How much do FIIs hold in Concord Biotech?
Foreign institutional investors held 7.52% of Concord Biotech as of 30-JUN-2026, a change of -0.28 pp from the previous quarter.
How much do domestic institutions hold in Concord Biotech?
Domestic institutional investors, including mutual funds and insurers, held 9.36% of Concord Biotech as of 30-JUN-2026 (+0.14 pp from the previous quarter).
Who owns Concord Biotech?
As of 30-JUN-2026, Concord Biotech's shareholders were promoters (44.08%), foreign institutional investors 7.52%, domestic institutions 9.36% and the public 39.03%, as filed with the stock exchanges.
Same Data For Peers
Trade Concord Biotech With ATS
Track CONCORDBIO live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.